Research Paper Volume 16, Issue 1 pp 43—65
An endoplasmic reticulum stress-related signature featuring ASNS for predicting prognosis and immune landscape in prostate cancer
Figure 7. Immune landscape and treatment response prediction. (A) Estimation of immune cell infiltration in high- and low-risk teams. (B) Explorations of immunological responses in terms of the ERscore risk groups. (C) Correlations between ERscore and immune checkpoints. (D) TIDE algorithm identified the difference in immunotherapy response between high- and low-risk groups. (E, F) The prediction of immunotherapy response using IMvigor210 and GSE70769 cohorts. (G) The prediction of chemotherapy response of PRAD patients with different ERscores. *p < 0.05, **p < 0.01, ***p < 0.001. Abbreviation: ns: not significant.